Pope Leo XIV Diagnosed with Lung Adenocarcinoma Following Successful Pulmonary Surgery
The Vatican has officially announced that Pope Leo XIV has been diagnosed with lung adenocarcinoma following a surgical intervention to remove a portion of his right lung. The medical briefing, released on Tuesday, October 13, confirmed that the procedure was carried out with precision and that the pontiff is currently recovering without any immediate postoperative complications. However, medical professionals at the facility continue to perform comprehensive evaluations to ascertain whether the malignant cells have migrated beyond the primary site.
The 71-year-old leader of the Catholic Church underwent a 90-minute operation at the Gemelli Hospital in Rome, during which surgeons excised the lower lobe of his right lung. This aggressive approach was deemed necessary to ensure the total removal of the tumor. Post-operative pathology reports have since validated the initial diagnosis of lung adenocarcinoma, aligning with the findings from pre-surgical screenings. Despite the gravity of the diagnosis, the Pope's resilience has been noted; sources indicate that he regained consciousness smoothly and showed a surprising appetite shortly after the procedure, requesting dinner upon his awakening.
According to a follow-up statement from the Vatican on Wednesday, the Pope experienced a tranquil night in the hospital. This medical crisis comes as a surprise to many, as the Pope had previously exhibited no visible symptoms of illness. The situation came to light on Sunday, October 11, when the Pope unexpectedly informed the faithful during the Angelus prayer at St. Peter's Square that a routine health check-up had revealed a nodule in his lung. He described the growth as being in a 'very early stage,' which prompted the immediate decision to operate.
From a clinical perspective, the early detection of this specific type of cancer is a critical factor. A spokesperson for the American Lung Association noted that the prognosis for lung adenocarcinoma is significantly improved when identified in its infancy. For patients where the malignancy is localized and has not metastasized, the five-year survival rate can range from 80% to 98%, although the exact outlook depends on the precise staging of the disease.
This health scare marks the first time Pope Leo XIV has been hospitalized since his election to the papacy on May 8, 2025. His ascension to the throne of St. Peter was historic, as he is the first American to serve as Pope. Known for his active lifestyle and commitment to physical fitness, his generally robust health had led many to believe he was in excellent condition for his age.
The impact of this diagnosis extends beyond his personal health to the administrative and diplomatic functions of the Holy See. The Vatican has already canceled all public audiences and scheduled engagements until October 20 to allow for a full week of recovery. Furthermore, the Pope's upcoming apostolic journey to South America—scheduled for November 6 through November 17, with planned visits to Uruguay, Argentina, and Peru—is now under review. While not officially canceled, the necessity of postoperative rehabilitation and the need for further diagnostic clarity have introduced significant uncertainty regarding his ability to travel.
As the global Catholic community awaits further updates, the focus remains on the Pope's recovery. The Vatican has urged for prayers and privacy as the medical team monitors his progress, ensuring that the transition from hospital care to his duties at the Apostolic Palace is handled with the necessary caution.